The Glittre Activities of Daily Living As a Potential Test for Functional Evaluation of Patients on Hemodialysis: a Validation Study
Overview
Authors
Affiliations
Purpose: To investigate the validity and within-day reliability of the Glittre activities of daily living test (Glittre ADL-test) in patients on hemodialysis.
Methods: Ninety-one patients on hemodialysis were evaluated using Glittre ADL-test, functional tests, health-related quality of life, human activity profile, and social participation. Convergent validity was analyzed by the correlation analysis. The Glittre ADL-test results were compared among different levels of the functional tests, human activity profile, and participation (known-groups validity). Within-day reliability was examined by Intra-class Correlation Coefficient (ICC).
Results: There was a significant moderate to strong correlation between Glittre ADL-test and functional tests ( = 0.62 to 0.66 and -0.70 to -0.44). A significant weak correlation was found between Glittre ADL-test, health-related quality of life ( = 0.28 to 0.32), and human activity profile (=-0.33). There was no significant correlation with participation. Except for participation level, the Glittre ADL-test results were able to identify individuals with low performance in all evaluated tests and were able to differentiate among inactive and active individuals by human activity profile ( < 0.05). Within-day reliability was evaluated in 42 patients. The ICC was 0.97.
Conclusion: The Glittre ADL-test is a reliable test associated with functional parameters and physical aspects related to health-related quality of life, with potential value in the functional evaluation of patients on hemodialysis.Implications for rehabilitationFunctional impairment is a common clinical finding and is an important predictor of poor prognosis in patients on hemodialysis.The Glittre ADL-test has excellent within-day reliability and is a valid instrument for functional assessment in patients on hemodialysis.Activity limitations of patients on hemodialysis can be assessed by Glittre ADL-test.
Safi F, Areshtanab H, Ghafourifard M, Ebrahimi H BMC Nephrol. 2024; 25(1):207.
PMID: 38918709 PMC: 11202372. DOI: 10.1186/s12882-024-03629-4.
MacRae J, Harasemiw O, Lightfoot C, Thompson S, Wytsma-Fisher K, Koufaki P Clin Kidney J. 2023; 16(11):2108-2128.
PMID: 37915888 PMC: 10616478. DOI: 10.1093/ckj/sfad170.
Balata M, Ferreira A, da Silva Sousa A, Meinertz L, de Sa L, Araujo V Healthcare (Basel). 2023; 11(12).
PMID: 37372926 PMC: 10298012. DOI: 10.3390/healthcare11121809.
Santos L, Figueiredo P, Silva A, Campos P, Goncalves G, de Paula C Freitas J BMC Nephrol. 2022; 23(1):119.
PMID: 35331148 PMC: 8944099. DOI: 10.1186/s12882-022-02719-5.